Optimal use of proton pump inhibitors for treating acid peptic diseases in primary care

被引：0

作者：

Tack, J. ^{[1
]}

Louis, E. ^{[2
,3
]}

Persy, V. ^{[4
]}

Urbain, D. ^{[5
]}

机构：

[1] Katholieke Univ Leuven, Translat Res Ctr Gastrointestinal Disorders, B-3000 Louvain, Belgium

[2] CHU, Liege, Belgium

[3] Univ Liege, Liege, Belgium

[4] Hugin Mugin Res, Antwerp, Belgium

[5] Vrije Univ Brussel, UZ Brussel, Dept Gastroenterol, Brussels, Belgium

来源：

ACTA GASTRO-ENTEROLOGICA BELGICA | 2013年 / 76卷 / 04期

关键词：

Proton pump inhibitors; acid peptic diseases; best practices; review; GASTROESOPHAGEAL-REFLUX DISEASE; FUNCTIONAL DYSPEPSIA; HELICOBACTER-PYLORI; CLINICAL-TRIALS; ESOPHAGEAL PH; PPI THERAPY; LIFE-STYLE; SYMPTOMATIC PATIENTS; GENERAL-POPULATION; DOUBLE-BLIND;

D O I：

暂无

中图分类号：

R57 [消化系及腹部疾病];

学科分类号：

摘要：

Heartburn, reflux and epigastric pain are frequently encountered symptoms in primary care medicine. Acid peptic diseases such as peptic ulcer and gastrointestinal reflux disease have a high prevalence, can have important impact on patient quality of life and represent a considerable health care cost. Proton pump inhibitors (PPIs) are the most potent pharmacological inhibitors of gastric acid secretion currently available and are the mainstay medical therapy for acid peptic diseases. This review summarizes current evidence on treatment of acid-peptic diseases with proton pump inhibitors and provides primary care clinicians with best practice guidelines for optimal use of these drugs.

引用

页码：393 / 402

页数：10

共 50 条

[41] Gastroesophageal reflux disease management and chronic use of proton pump inhibitors
Howland, Anne M.
JAAPA-JOURNAL OF THE AMERICAN ACADEMY OF PHYSICIAN ASSISTANTS, 2023, 36 (12):
[42] Intravenous proton pump inhibitors in the critical care setting
Morgan, D
CRITICAL CARE MEDICINE, 2002, 30 (06) : S369 - S372
[43] Science review: The use of proton pump inhibitors for gastric acid suppression in critical illness
Brett, S
CRITICAL CARE, 2005, 9 (01) : 45 - 50
[44] Science review: The use of proton pump inhibitors for gastric acid suppression in critical illness
Stephen Brett
Critical Care, 9
[45] The impact of proton pump inhibitors in liver diseases and the effects on the liver
Liu, Yuan Bin
Chen, Ming Kai
JOURNAL OF DIGESTIVE DISEASES, 2022, 23 (04) : 196 - 208
[46] Safety of proton-pump inhibitors: the acid test
Moncur, PH
Heatley, RV
EUROPEAN JOURNAL OF GASTROENTEROLOGY & HEPATOLOGY, 2000, 12 (02) : 145 - 147
[47] Marked increase in proton pump inhibitors use in Australia
Hollingworth, Samantha
Duncan, Emma L.
Martin, Jennifer H.
PHARMACOEPIDEMIOLOGY AND DRUG SAFETY, 2010, 19 (10) : 1019 - 1024
[48] Use of proton pump inhibitors and risk of pancreatic cancer
Hicks, Blanaid
Friis, Soren
Pottegard, Anton
PHARMACOEPIDEMIOLOGY AND DRUG SAFETY, 2018, 27 (08) : 926 - 930
[49] A Rationale for the Use of Proton Pump Inhibitors as Antineoplastic Agents
De Milito, Angelo
Marino, Maria Lucia
Fais, Stefano
CURRENT PHARMACEUTICAL DESIGN, 2012, 18 (10) : 1395 - 1406
[50] The Use and Misuse of Proton Pump Inhibitors: An Opportunity for Deprescribing
Dharmarajan, Thiruvinvamalai S.
JOURNAL OF THE AMERICAN MEDICAL DIRECTORS ASSOCIATION, 2021, 22 (01) : 15 - 22

← 1 2 3 4 5 →